Results 51 to 60 of about 3,073,677 (383)
Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke.
New England Journal of Medicine, 2008 BACKGROUND Intravenous thrombolysis with alteplase is the only approved treatment for acute ischemic stroke, but its efficacy and safety when administered more than 3 hours after the onset of symptoms have not been established. We tested the efficacy and
W. Hacke +13 more
semanticscholar +1 more source
Health professionals' perceptions of cultural influences on stroke experiences and rehabilitation in Kuwait [PDF]
, 2011 This is the author's accepted manuscript. The final published article is available from the link below. Copyright @ 2012 Informa UK Ltd.Purpose: The aim of this study was to investigate the perceptions of health professionals who treat stroke patients in
Omu, O, Reynolds, F
core +1 more source
Circulation, 2009 We thank Drs Sean Coady, Eric L. Ding, Brian Eigel, Gregg C. Fonarow, Linda Geiss, Cherie James, Michael Mussolino, and Michael Wolz for their valuable comments and contributions.
D. Lloyd‐Jones +34 more
semanticscholar +2 more sources
Frontiers in Neurology, 2017 Background and aimThe availability and access of hospital administrative data [coding for Charlson comorbidity index (CCI)] in large data form has resulted in a surge of interest in using this information to predict mortality from stroke.
Thanh G. Phan +4 more
doaj +1 more source
BMJ, 2015 #### The bottom line Stroke is increasingly common and often fatal or disabling.1 The absence of a definitive diagnostic test for stroke and the potential for emergency interventions to restore brain perfusion,2 improve survival free of handicap, and minimise early recurrent stroke3 mean that doctors need to be able to diagnose acute stroke rapidly ...
David Blacker +2 more
openaire +2 more sources
microRNA expression in peripheral blood cells following acute ischemic stroke and their predicted gene targets. [PDF]
, 2014 BackgroundmicroRNA (miRNA) are important regulators of gene expression. In patients with ischemic stroke we have previously shown that differences in immune cell gene expression are present.
Ander, Bradley P +5 more
core +3 more sources
Enhanced clarity and holism: The outcome of implementing the ICF with an acute stroke multidisciplinary team in England [PDF]
, 2013 This article is made available through the Brunel Open Access Publishing Fund.Purpose: Although it is recommended that the ICF (International Classification of Functioning, Disability and Health) should be implemented to aid communication within ...
Borkan J +11 more
core +1 more source
Detection of C8/T1 radiculopathy by measuring the root motor conduction time
BMC Neurology, 2022 Background Root motor conduction time (RMCT) can noninvasively evaluate the status of the proximal root segment. However, its clinical application remains limited, and wider studies regarding its use are scarce.
Dougho Park +6 more
doaj +1 more source
The LancetStroke affects up to one in five people during their lifetime in some high-income countries, and up to almost one in two in low-income countries. Globally, it is the second leading cause of death. Clinically, the disease is characterised by sudden neurological deficits.
Hilkens, N.A. +3 more
openaire +3 more sources
To Tube or Not to Tube? The Role of Intubation during Stroke Thrombectomy. [PDF]
, 2014 In the 10 years since the FDA first cleared the use of endovascular devices for the treatment of acute stroke, definitive evidence that such therapy improves outcomes remains lacking.
Hinman, Jason D +3 more
core +2 more sources